STCOSD
ABMD

Sageworth Trust Company of South Dakota’s Abiomed Inc ABMD Stock Holding History

Sageworth Trust Company of South Dakota’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-16
Closed -$4K – 706
2022
Q2 		$4K Hold
16
– – 0.01% 278
2022
Q1 		$5K Sell
16
-79
-83% -$24.3K 0.01% 306
2021
Q4 		$34K Buy
+95
New +$32.1K 0.05% 149

Other funds holding ABMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
Winslow Capital Management
Winslow Capital Management Minneapolis, Minnesota $25.6B AUM 33.75% 1-Year Est. Return

Sageworth Trust Company of South Dakota's ABMD Position: Q3 2022 in Review

Sageworth Trust Company of South Dakota sold out of Abiomed Inc (ABMD) in Q3 2022, closing a stake of 16 shares — an estimated $4K sold.

Sageworth Trust Company of South Dakota first reported a position in ABMD in Q4 2021 and held it in 3 quarters. The position peaked at $34K in Q4 2021. 517 funds tracked by Wall St. Rank hold ABMD as of Q3 2022.

  • Sageworth Trust Company of South Dakota reported no remaining Abiomed Inc position as of Q3 2022 after selling out during the quarter.
  • Sageworth Trust Company of South Dakota sold 16 Abiomed Inc shares in Q3 2022, an estimated $4K.
  • Sageworth Trust Company of South Dakota first reported a position in Abiomed Inc in Q4 2021 and held it in 3 quarters.
  • Sageworth Trust Company of South Dakota's Abiomed Inc position peaked at $34K in Q4 2021.
  • 517 funds tracked by Wall St. Rank held Abiomed Inc as of Q3 2022.

Based on Sageworth Trust Company of South Dakota's 13F filing for Q3 2022, filed 2 Nov 2022.